Melita Irving

4 Patents

• US125288472026

  Heterodimeric Inactivatable Chimeric Antigen Receptors

  éCole Polytechnique Fédérale De Lausanne

  0 cites
• US124786262025

  Kinase Mutants and Uses Thereof

  Ludwig Institute For Cancer Research Ltd.

  0 cites
• US124733462025

  A2/NY-ESO-1 Specific T Cell Receptors and Uses Thereof

  LUDWIG INSTITUTE FOR CANCER RESEARCH Ltd

  0 cites
• US117380492023

  Kinase Mutants and Uses Thereof

  Ludwig Institute For Cancer Research Ltd

  0 cites